Deutsche Kinderkrebsstiftung   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Bonn Germany (1995)

Organization Overview

First Clinical Trial
2009
NCT00876031
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Deutsche Kinderkrebsstiftung

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Astrocytoma (Phase 3)

Brain Neoplasms (Phase 3)

Glioblastoma (Phase 3)

Glioma (Phase 3)

Medulloblastoma (Phase 3)

Neoplasms, Germ Cell and Embryonal (Phase 4)

Neoplasms, Neuroepithelial (Phase 3)

Rhabdomyosarcoma (Phase 3)

Sarcoma (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 11